Company attributes
Location
AngelList URL
Pitchbook URL
Legal Name
AJU IB INVESTMENT Co., Ltd.
Legal classification
Number of Employees (Ranges)
11 – 50
Email Address
info@ajuib.co.kr
Phone Number
+82234519200
Full Address
201, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea
Founded Date
September 9, 1974
Fax Number
+82 2-3452-9805
+82 2-3452-9804
Stock Symbol
027360
Exchange
Wellfound ID
Country
Headquarters
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Aju IB Investment is a venture capital firm in South Korea that focuses on providing investments for SMEs across all stages of development. Founded 1974 in Yeoksamdong, South Korea, it invests in late stage ventures. Its portfolio companies include Seer, SparkPlus, FamePick, Arcellx, Amphivena Therapeutics, Trefoil Therapeutics, Tibit Communications, Kymera Therapeutics, and Albam. As of March 2020, Aju IB Investment has made 27 investments. Their most recent investment was on December 17, 2019, when Seer raised $55M. Aju IB Investment has had nine exits, the most notable of which include Synlogic, Apellis Pharmaceuticals, and Molecular Templates. The company has raised a single venture fund, AJU IB Investment.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Associated Investment Funds
Accelerator Batches
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
